Friday, August 22, 2025 10:57:29 AM
YOU ARE SO WRONG as it was patented in 2022, OH and since you are not up to speed, A TRADE MARK IS NOT A PATENT as it only has to do with A PRODUCTS NAME
According to public records, (((((((((((((((((((((((((((((((((((((((((((((((a patent application for the hydrogel component of RadioGel™/IsoPet® was filed on
September 14, 2022,)))))))))))))))))))))))))))))))))))))))))))))) in both the USA (application number 17/943,311) and internationally (PCT/US22/43274) under the Patent Cooperation Treaty.
Additionally, a utility patent application for a range of particles used in precision radionuclide therapy was filed on January 11, 2023, following a provisional patent application filed on January 15, 2022. These patent applications cover countries such as the USA, Canada, the EU, Japan, Australia, Brazil, China, India, South Korea, and Russia.
It's important to note that the term "RadioGel™" itself is a trademark, with the trademark registration number 5370277, filed on November 14, 2013, and registered on January 2, 2018.
According to public records, (((((((((((((((((((((((((((((((((((((((((((((((a patent application for the hydrogel component of RadioGel™/IsoPet® was filed on
September 14, 2022,)))))))))))))))))))))))))))))))))))))))))))))) in both the USA (application number 17/943,311) and internationally (PCT/US22/43274) under the Patent Cooperation Treaty.
Additionally, a utility patent application for a range of particles used in precision radionuclide therapy was filed on January 11, 2023, following a provisional patent application filed on January 15, 2022. These patent applications cover countries such as the USA, Canada, the EU, Japan, Australia, Brazil, China, India, South Korea, and Russia.
It's important to note that the term "RadioGel™" itself is a trademark, with the trademark registration number 5370277, filed on November 14, 2013, and registered on January 2, 2018.
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
